COPD Management
COPD management should be based on a stepwise pharmacologic approach using long-acting bronchodilators as the foundation, combined with non-pharmacologic interventions including pulmonary rehabilitation, smoking cessation, and supplemental oxygen for patients with resting hypoxemia.
Pharmacologic Management
Stable COPD - Initial Therapy
Long-acting bronchodilators are the cornerstone of maintenance therapy and should be initiated when dyspnea limits activity or quality of life 1, 2.
First-line options include:
Short-acting bronchodilators (beta-agonists with or without anticholinergics) should be used for rescue therapy during acute symptom worsening 1
Escalation Based on Exacerbation History
For patients experiencing exacerbations despite long-acting bronchodilator therapy:
- Add inhaled corticosteroids (ICS) to LABA therapy, particularly if blood eosinophil count is elevated 1, 4, 2
- LAMA + LABA + ICS triple therapy for patients with FEV1 <50% predicted and recurrent exacerbations 1
- Consider macrolide antibiotics (in former smokers) for patients with persistent exacerbations despite optimal inhaled therapy 1
Important caveat: ICS + LABA reduced mortality compared to placebo (relative risk 0.82) and ICS alone (relative risk 0.79), though absolute reductions were ≤1% 5. Routine corticosteroids should be avoided in stable disease 6.
Precision Medicine Approach
Blood eosinophil count (BEC) should guide ICS use as a biomarker for type 2 inflammation 4:
- Higher BEC predicts greater response to ICS therapy 4
- Exacerbations with elevated sputum or blood eosinophils are more responsive to systemic steroids 1
Medications to Avoid
- Methylxanthines (theophylline) are not recommended due to side effects 1
- Short-acting anticholinergic inhalers are not recommended for maintenance 6
- Nebulized opioids are not recommended 6
Non-Pharmacologic Management
Pulmonary Rehabilitation
Pulmonary rehabilitation should be prescribed for all symptomatic patients as it improves health status, dyspnea, and exercise tolerance 1, 5, 2.
- Includes strength and endurance training, educational support, nutritional counseling, and psychosocial support 2
- Critical pitfall: Pulmonary rehabilitation is underutilized despite strong evidence 2 and should be avoided during acute hospitalization for exacerbations 6
Oxygen Therapy
Long-term oxygen therapy (LTOT) is indicated for patients with chronic severe hypoxemia and is the only intervention proven to reduce mortality 1, 5, 2:
- PaO2 ≤55 mmHg (7.3 kPa) or SpO2 ≤88% confirmed twice over 3 weeks 1
- PaO2 55-60 mmHg (7.3-8.0 kPa) or SpO2 88% with evidence of pulmonary hypertension, peripheral edema, or polycythemia (hematocrit >55%) 1
- Supplemental oxygen reduced mortality (relative risk 0.61) in symptomatic patients with resting hypoxia 5
Ambulatory oxygen without resting hypoxemia is not recommended 5, 6
Smoking Cessation
All patients must receive smoking cessation counseling as this is the most effective intervention to slow disease progression 1, 2.
Vaccination
Influenza vaccination is recommended for all COPD patients 1.
Pneumococcal vaccination (PCV13 and PPSV23) is recommended for:
- All patients ≥65 years 1
- Younger patients with significant comorbidities including chronic heart or lung disease 1
Nutritional Support
Nutritional supplementation is recommended for malnourished patients with COPD 1.
Exacerbation Management
Classification and Treatment
COPD exacerbations are classified by severity and treated accordingly 1:
- Mild: Short-acting bronchodilators only 1
- Moderate: Short-acting bronchodilators + antibiotics and/or oral corticosteroids 1
- Severe: Requires hospitalization or emergency department visit 1
Acute Exacerbation Treatment
Short-acting inhaled beta-agonists, with or without short-acting anticholinergics, are the initial bronchodilators for acute exacerbations 1.
Systemic corticosteroids improve lung function, oxygenation, and shorten recovery time and hospitalization duration 1.
Antibiotics, when indicated, shorten recovery time and reduce risk of early relapse, treatment failure, and hospitalization duration 1.
Non-invasive ventilation (NIV) should be the first mode of ventilation for acute respiratory failure 1.
Post-Exacerbation Management
Maintenance therapy with long-acting bronchodilators should be initiated as soon as possible before hospital discharge 1.
Exacerbation prevention measures must be implemented after any exacerbation 1.
Advanced Interventions
Ventilatory Support
NIV may be considered in selected patients with pronounced daytime hypercapnia and recent hospitalization 1.
Continuous positive airway pressure (CPAP) is indicated for patients with both COPD and obstructive sleep apnea 1.
Surgical Options
Lung volume reduction (surgical or bronchoscopic with endobronchial valves/coils) may be considered in selected patients with heterogeneous or homogeneous emphysema and significant hyperinflation refractory to optimized medical care 1.
Surgical bullectomy may be considered in selected patients with large bullae 1.
Lung Transplantation
Referral criteria for lung transplantation include 1:
- Progressive disease not amenable to lung volume reduction
- BODE index 5-6
- PCO2 >50 mmHg (6.6 kPa) and/or PaO2 <60 mmHg (8 kPa)
- FEV1 <25% predicted
Listing criteria include one of the following 1:
- BODE index >7
- FEV1 <15-20% predicted
- Three or more severe exacerbations in preceding year
- One severe exacerbation with acute hypercapnic respiratory failure
- Moderate to severe pulmonary hypertension
Monitoring and Follow-up
Routine follow-up is essential to monitor symptoms, exacerbations, and objective measures of airflow limitation 1.
Each follow-up visit should include discussion of the current therapeutic regimen to adjust therapy as disease progresses 1.
Symptoms indicating worsening or development of comorbid conditions should be evaluated and treated 1.
Self-Management and Education
Educational programs should include 1:
- Smoking cessation strategies
- Basic COPD information
- Proper use of respiratory medications and inhalation devices
- Strategies to minimize dyspnea
- When to seek medical help
- Advance directives and end-of-life discussions
Exacerbation action plans should be provided to reduce hospitalizations 6, 3.